genetic markers for breast and ovarian cancer.

摘要

SPECIFIC USED BRCA1, PCR primers and probes hybridization PROCEDURES FOR NUCLEIC ACIDS BASED ON THE DIAGNOSIS OF BREAST CANCER SUSCEPTIBILITY hereditary. They are also used binding agents such as antibodies specific for the peptides encoded by BRCA1 DESCRIBED THE MUTANT to identify expression products DIAGNOSTICS mutational / rare alleles SAMPLES IN fluid or tissue derived from a patient. USED ​​compositions with a high binding affinity FOR PRODUCTS transcription or translation of BRCA1 Mutations Alleles DESCRIBED AND IN THERAPEUTIC INTERVENTIONS. These products include nucleic acids BY ANTI Nucleic acids described and binding agents such as antibodies, which are specific for such peptides.